Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
Study Information
Alliance Study ID: CALGB-150509
NCT Study ID (ClinicalTrials.gov): NCT00898547
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Robert A. Kratzke, MD
Status: TERMINATED
Study Description
RATIONALE: Collecting and storing samples of blood from patients with cancer to study in the laboratory may help doctors learn more about cancer and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at biomarkers of angiogenesis and disease in patients with unresectable malignant mesothelioma treated on clinical trial CALGB-30107.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information